Last update 08 Mar 2025

TD-016

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
TD-016
Target
ALK
Action-
Mechanism
ALK inhibitors(Anaplastic lymphoma kinase inhibitors)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
ALK positive Non-Small Cell Lung Cancer
Inactive Indication-
Originator Organization
Korea Research Institute of Chemical TechnologyKorea Research Institute of Chemical TechnologyChungnam National UniversityChungnam National University
Active Organization
Korea Research Institute of Chemical TechnologyKorea Research Institute of Chemical TechnologyChungnam National UniversityChungnam National University
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC57H74ClN9O8S2
InChIKeyZZMFLQGXQVEFQJ-UBBOFEIVSA-N
CAS Registry2162120-63-8

Related

100 Clinical Results associated with TD-016
Login to view more data
100 Translational Medicine associated with TD-016
Login to view more data
100 Patents (Medical) associated with TD-016
Login to view more data
100 Deals associated with TD-016
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ALK positive Non-Small Cell Lung CancerPreclinical
South Korea
Korea Research Institute of Chemical TechnologyKorea Research Institute of Chemical Technology
01 Oct 2018
ALK positive Non-Small Cell Lung CancerPreclinical
South Korea
Chungnam National UniversityChungnam National University
01 Oct 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free